NrCAM is a physiological substrate for disintegrin and metalloprotease 10 (ADAM10), which is involved in amyloid precursor protein (APP) cleavage, so may exert a protective role in AD and therefore become a potential therapeutic target [22]. This evidence concerns the gene APP and Alzheimer disease.